Skip to content

Effect and experience of intra-arterial chemoembolization for treatment of gynecological tumors

Effect and experience of intra-arterial chemoembolization for treatment of gynecological tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096373
Enrollment
Unknown
Registered
2025-01-22
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological malignancies

Interventions

Gynecological malignant tumor group:None

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. patients with gynecological malignant tumors diagnosed by pathology; 2. patients who underwent transarterial chemoembolization to reduce the size of the tumor before radical surgery to improve the radical rate of surgery; 3. patients who had undergone radical surgery and relapsed, or who were in poor general condition and did not meet the conditions for surgery, or who had developed to end-stage palliative treatment; 4. patients who voluntarily accepted interventional treatment. ? willing to accept interventional surgery.

Exclusion criteria

Exclusion criteria: 1. patients with gynecological benign tumors and scar pregnancy; 2. patients with thrombocytopenia, difficulty in hemostasis, vascular injury or vascular diseases; 3. patients with severe dysfunction of heart, liver, kidney and brain that cannot be treated by interventional surgery; 4. patients with inflammatory and infectious diseases; 5. patients with contrast agent allergy; 6. patients who could not complete the follow-up or failed to follow up in time according to the doctor's advice.

Design outcomes

Primary

MeasureTime frame
Imaging findings;Hemoglobin;Liver function;Renal function;Tumor markers;

Countries

China

Contacts

Public ContactXiao An

Shanghai General Hospital

drxiaoan@126.com+86 138 1628 7103

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026